The protective mechanism of IL-27 involves inhibiting the phosphorylation of STAT1 and STAT5, thereby suppressing JAK/STAT pathway activity and ultimately inhibiting IPF [51]. This evidence concerns the gene STAT1 and idiopathic pulmonary fibrosis.